Journal article
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation
Abstract
AIMS: To determine whether the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) integrated risk tool predicts mortality, non-haemorrhagic stroke/systemic embolism, and major bleeding for up to 2 years after new-onset AF and to assess how this risk tool performs compared with CHA2DS2-VASc and HAS-BLED.
METHODS AND RESULTS: Potential predictors of events included demographic and clinical characteristics, choice of …
Authors
Fox KAA; Virdone S; Pieper KS; Bassand J-P; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G
Journal
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 8, No. 2, pp. 214–227
Publisher
Oxford University Press (OUP)
Publication Date
March 2, 2022
DOI
10.1093/ehjqcco/qcab028
ISSN
2058-5225